SCHEMBL30249024

SCHEMBL30249024

CN(C)CCc1c[nH]c2cccc(OCOC(=O)CCCCC(=O)OC(C)(C)C)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 4/20 0.55
▸ HTR2A P28223 8/20 0.54
▸ HTR1A P08908 6/20 0.54
▸ HTR2C P28335 5/20 0.54
▸ HTR2B P41595 5/20 0.54
▸ HTR1B P28222 4/20 0.51
▸ HTR7 P34969 2/20 0.51
▸ HTR5A P47898 2/20 0.51
▸ HTR1D P28221 2/20 0.51
▸ DRD1 P21728 1/20 0.51
▸ HTR1E P28566 1/20 0.51
▸ ADORA2A P29274 1/20 0.51
▸ ADORA2B P29275 1/20 0.51
▸ DRD3 P35462 1/20 0.51
▸ HTR1F P30939 1/20 0.45
▸ SLC6A4 P31645 1/20 0.42
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ SLC6A2 P23975 1/20 0.40
▸ ADRA2A P08913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25074527 1.00 HTR6 (0.55) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL25074534 0.98 HTR6 (0.55) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL31320742 0.98 HTR6 (0.55) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL30928239 0.96 HTR6 (0.57) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL25074532 0.96 HTR6 (0.57) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL31320737 0.89 HTR2A (0.67) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL25074599 0.89 HTR6 (0.58) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL29259001 0.89 HTR2A (0.60) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL29259496 0.89 HTR6 (0.65) HTR6HTR2AHTR1AHTR2CHTR2B
SCHEMBL26307634 0.88 HTR2A (0.63) HTR6HTR2AHTR1AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011344-A1 PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF TERRAN BIOSCIENCES INC (US) 2025-01-09 — — US disclosed
EP-4387608-A1 PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF Terran Biosciences, Inc. (US) 2024-06-26 — — EP disclosed
WO-2023023347-A1 PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF TERRAN BIOSCIENCES INC. (US) 2023-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011344-A1 PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF PSAP, PIGO, PSAT1 HTR6 510/4885HTR2A 668/4885HTR1A 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback